(Reuters) – Drug distributor Cencora raised its annual adjusted profit forecast on Thursday.
Excluding one-off items, the company now sees its 2024 profit to be between $15.15 and $15.45 per share, compared with its previous range of $14.80 to $15.10 per share.
(Reporting by Puyaan Singh in Bengaluru; Editing by Mohammed Safi Shamsi)
Comments